Report Detail

Pharma & Healthcare Global Levonorgestrel API Market Research Report 2020

  • RnM3940660
  • |
  • 30 March, 2020
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Levonorgestrel API Market Overview

    • 1.1 Product Overview and Scope of Levonorgestrel API
    • 1.2 Levonorgestrel API Segment by Type
      • 1.2.1 Global Levonorgestrel API Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Short-Acting Contraceptive API
      • 1.2.3 Long-Acting Contraceptive API
    • 1.3 Levonorgestrel API Segment by Application
      • 1.3.1 Levonorgestrel API Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Table
      • 1.3.3 Mixture Products
      • 1.3.4 Other
    • 1.4 Global Levonorgestrel API Market Size Estimates and Forecasts
      • 1.4.1 Global Levonorgestrel API Revenue 2015-2026
      • 1.4.2 Global Levonorgestrel API Sales 2015-2026
      • 1.4.3 Levonorgestrel API Market Size by Region: 2020 Versus 2026

    2 Global Levonorgestrel API Market Competition by Manufacturers

    • 2.1 Global Levonorgestrel API Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Levonorgestrel API Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Levonorgestrel API Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Levonorgestrel API Manufacturing Sites, Area Served, Product Type
    • 2.5 Levonorgestrel API Market Competitive Situation and Trends
      • 2.5.1 Levonorgestrel API Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Levonorgestrel API Players (Opinion Leaders)

    3 Levonorgestrel API Retrospective Market Scenario by Region

    • 3.1 Global Levonorgestrel API Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Levonorgestrel API Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Levonorgestrel API Market Facts & Figures by Country
      • 3.3.1 North America Levonorgestrel API Sales by Country
      • 3.3.2 North America Levonorgestrel API Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Levonorgestrel API Market Facts & Figures by Country
      • 3.4.1 Europe Levonorgestrel API Sales by Country
      • 3.4.2 Europe Levonorgestrel API Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Levonorgestrel API Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Levonorgestrel API Sales by Region
      • 3.5.2 Asia Pacific Levonorgestrel API Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Levonorgestrel API Market Facts & Figures by Country
      • 3.6.1 Latin America Levonorgestrel API Sales by Country
      • 3.6.2 Latin America Levonorgestrel API Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Levonorgestrel API Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Levonorgestrel API Sales by Country
      • 3.7.2 Middle East and Africa Levonorgestrel API Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Levonorgestrel API Historic Market Analysis by Type

    • 4.1 Global Levonorgestrel API Sales Market Share by Type (2015-2020)
    • 4.2 Global Levonorgestrel API Revenue Market Share by Type (2015-2020)
    • 4.3 Global Levonorgestrel API Price Market Share by Type (2015-2020)
    • 4.4 Global Levonorgestrel API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Levonorgestrel API Historic Market Analysis by Application

    • 5.1 Global Levonorgestrel API Sales Market Share by Application (2015-2020)
    • 5.2 Global Levonorgestrel API Revenue Market Share by Application (2015-2020)
    • 5.3 Global Levonorgestrel API Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Levonorgestrel API Business

    • 6.1 ScinoPharm
      • 6.1.1 Corporation Information
      • 6.1.2 ScinoPharm Description, Business Overview and Total Revenue
      • 6.1.3 ScinoPharm Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 ScinoPharm Products Offered
      • 6.1.5 ScinoPharm Recent Development
    • 6.2 Altaris (3M Drug Delivery Systems)
      • 6.2.1 Altaris (3M Drug Delivery Systems) Levonorgestrel API Production Sites and Area Served
      • 6.2.2 Altaris (3M Drug Delivery Systems) Description, Business Overview and Total Revenue
      • 6.2.3 Altaris (3M Drug Delivery Systems) Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Altaris (3M Drug Delivery Systems) Products Offered
      • 6.2.5 Altaris (3M Drug Delivery Systems) Recent Development
    • 6.3 Bayer
      • 6.3.1 Bayer Levonorgestrel API Production Sites and Area Served
      • 6.3.2 Bayer Description, Business Overview and Total Revenue
      • 6.3.3 Bayer Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Bayer Products Offered
      • 6.3.5 Bayer Recent Development
    • 6.4 Cipla
      • 6.4.1 Cipla Levonorgestrel API Production Sites and Area Served
      • 6.4.2 Cipla Description, Business Overview and Total Revenue
      • 6.4.3 Cipla Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Cipla Products Offered
      • 6.4.5 Cipla Recent Development
    • 6.5 Formos
      • 6.5.1 Formos Levonorgestrel API Production Sites and Area Served
      • 6.5.2 Formos Description, Business Overview and Total Revenue
      • 6.5.3 Formos Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Formos Products Offered
      • 6.5.5 Formos Recent Development
    • 6.6 FORTEQ NIDAU AG
      • 6.6.1 FORTEQ NIDAU AG Levonorgestrel API Production Sites and Area Served
      • 6.6.2 FORTEQ NIDAU AG Description, Business Overview and Total Revenue
      • 6.6.3 FORTEQ NIDAU AG Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 FORTEQ NIDAU AG Products Offered
      • 6.6.5 FORTEQ NIDAU AG Recent Development
    • 6.7 Gedeon Richter
      • 6.6.1 Gedeon Richter Levonorgestrel API Production Sites and Area Served
      • 6.6.2 Gedeon Richter Description, Business Overview and Total Revenue
      • 6.6.3 Gedeon Richter Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Gedeon Richter Products Offered
      • 6.7.5 Gedeon Richter Recent Development
    • 6.8 Hangzhou Longshine Bio-Tec
      • 6.8.1 Hangzhou Longshine Bio-Tec Levonorgestrel API Production Sites and Area Served
      • 6.8.2 Hangzhou Longshine Bio-Tec Description, Business Overview and Total Revenue
      • 6.8.3 Hangzhou Longshine Bio-Tec Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Hangzhou Longshine Bio-Tec Products Offered
      • 6.8.5 Hangzhou Longshine Bio-Tec Recent Development
    • 6.9 Hubei Gedian Humanwell Pharmaceutical
      • 6.9.1 Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Production Sites and Area Served
      • 6.9.2 Hubei Gedian Humanwell Pharmaceutical Description, Business Overview and Total Revenue
      • 6.9.3 Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 Hubei Gedian Humanwell Pharmaceutical Products Offered
      • 6.9.5 Hubei Gedian Humanwell Pharmaceutical Recent Development
    • 6.10 Indo Phyto Chemicals
      • 6.10.1 Indo Phyto Chemicals Levonorgestrel API Production Sites and Area Served
      • 6.10.2 Indo Phyto Chemicals Description, Business Overview and Total Revenue
      • 6.10.3 Indo Phyto Chemicals Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Indo Phyto Chemicals Products Offered
      • 6.10.5 Indo Phyto Chemicals Recent Development
    • 6.11 Industriale Chimica
      • 6.11.1 Industriale Chimica Levonorgestrel API Production Sites and Area Served
      • 6.11.2 Industriale Chimica Levonorgestrel API Description, Business Overview and Total Revenue
      • 6.11.3 Industriale Chimica Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Industriale Chimica Products Offered
      • 6.11.5 Industriale Chimica Recent Development
    • 6.12 Jenapharm
      • 6.12.1 Jenapharm Levonorgestrel API Production Sites and Area Served
      • 6.12.2 Jenapharm Levonorgestrel API Description, Business Overview and Total Revenue
      • 6.12.3 Jenapharm Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Jenapharm Products Offered
      • 6.12.5 Jenapharm Recent Development
    • 6.13 Lupin
      • 6.13.1 Lupin Levonorgestrel API Production Sites and Area Served
      • 6.13.2 Lupin Levonorgestrel API Description, Business Overview and Total Revenue
      • 6.13.3 Lupin Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 Lupin Products Offered
      • 6.13.5 Lupin Recent Development
    • 6.14 Naari
      • 6.14.1 Naari Levonorgestrel API Production Sites and Area Served
      • 6.14.2 Naari Levonorgestrel API Description, Business Overview and Total Revenue
      • 6.14.3 Naari Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 Naari Products Offered
      • 6.14.5 Naari Recent Development
    • 6.15 Qinhuangdao Zizhu Pharmaceutical
      • 6.15.1 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Production Sites and Area Served
      • 6.15.2 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Description, Business Overview and Total Revenue
      • 6.15.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.15.4 Qinhuangdao Zizhu Pharmaceutical Products Offered
      • 6.15.5 Qinhuangdao Zizhu Pharmaceutical Recent Development
    • 6.16 Sterling Chemical Malta Ltd
      • 6.16.1 Sterling Chemical Malta Ltd Levonorgestrel API Production Sites and Area Served
      • 6.16.2 Sterling Chemical Malta Ltd Levonorgestrel API Description, Business Overview and Total Revenue
      • 6.16.3 Sterling Chemical Malta Ltd Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.16.4 Sterling Chemical Malta Ltd Products Offered
      • 6.16.5 Sterling Chemical Malta Ltd Recent Development
    • 6.17 Symbiotec Pharmalab
      • 6.17.1 Symbiotec Pharmalab Levonorgestrel API Production Sites and Area Served
      • 6.17.2 Symbiotec Pharmalab Levonorgestrel API Description, Business Overview and Total Revenue
      • 6.17.3 Symbiotec Pharmalab Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.17.4 Symbiotec Pharmalab Products Offered
      • 6.17.5 Symbiotec Pharmalab Recent Development
    • 6.18 Yangzhou Pharmaceutical
      • 6.18.1 Yangzhou Pharmaceutical Levonorgestrel API Production Sites and Area Served
      • 6.18.2 Yangzhou Pharmaceutical Levonorgestrel API Description, Business Overview and Total Revenue
      • 6.18.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2015-2020)
      • 6.18.4 Yangzhou Pharmaceutical Products Offered
      • 6.18.5 Yangzhou Pharmaceutical Recent Development

    7 Levonorgestrel API Manufacturing Cost Analysis

    • 7.1 Levonorgestrel API Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Levonorgestrel API
    • 7.4 Levonorgestrel API Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Levonorgestrel API Distributors List
    • 8.3 Levonorgestrel API Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Levonorgestrel API Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Levonorgestrel API by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Levonorgestrel API by Type (2021-2026)
    • 10.2 Levonorgestrel API Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Levonorgestrel API by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Levonorgestrel API by Application (2021-2026)
    • 10.3 Levonorgestrel API Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Levonorgestrel API by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Levonorgestrel API by Region (2021-2026)
    • 10.4 North America Levonorgestrel API Estimates and Projections (2021-2026)
    • 10.5 Europe Levonorgestrel API Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Levonorgestrel API Estimates and Projections (2021-2026)
    • 10.7 Latin America Levonorgestrel API Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Levonorgestrel API Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Levonorgestrel API market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on Levonorgestrel API volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Levonorgestrel API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Levonorgestrel API market is segmented into
      Short-Acting Contraceptive API
      Long-Acting Contraceptive API

      Segment by Application
      Table
      Mixture Products
      Other

      Global Levonorgestrel API Market: Regional Analysis
      The Levonorgestrel API market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Levonorgestrel API market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Levonorgestrel API Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Levonorgestrel API market include:
      ScinoPharm
      Altaris (3M Drug Delivery Systems)
      Bayer
      Cipla
      Formos
      FORTEQ NIDAU AG
      Gedeon Richter
      Hangzhou Longshine Bio-Tec
      Hubei Gedian Humanwell Pharmaceutical
      Indo Phyto Chemicals
      Industriale Chimica
      Jenapharm
      Lupin
      Naari
      Qinhuangdao Zizhu Pharmaceutical
      Sterling Chemical Malta Ltd
      Symbiotec Pharmalab
      Yangzhou Pharmaceutical


      Summary:
      Get latest Market Research Reports on Levonorgestrel API. Industry analysis & Market Report on Levonorgestrel API is a syndicated market report, published as Global Levonorgestrel API Market Research Report 2020. It is complete Research Study and Industry Analysis of Levonorgestrel API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $4,350.00
      $5,800.00
      2,133.33
      3,200.00
      4,266.67
      2,395.37
      3,593.06
      4,790.75
      300,970.70
      451,456.05
      601,941.40
      212,316.54
      318,474.81
      424,633.08
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report